Inventor · disambiguated record
Jin Li
Also filed as: LI JIN · LI JIN-PING
43 granted patents·37 pending applications·186 citations·filing 2000–2025
97Inventor score
Top patents by PatentIndex Score
80 records- 0193US11219675B2Methods of cancer treatment using activated T cellsSYZ CELL THERAPY CO·Filed 2020·Granted Jan 11, 2022·4 cites·18 claims
- 0292US11229689B2Methods of cancer treatment using activated T cellsSYZ CELL THERAPY CO·Filed 2021·Granted Jan 25, 2022·3 cites·12 claims
- 0392US6949572B2Triamide-substituted heterobicyclic compoundsPFIZER·Filed 2003·Granted Sep 27, 2005·45 cites·54 claims
- 0491US6979692B2Triamide-substituted heterobicyclic compoundsPFIZER·Filed 2003·Granted Dec 27, 2005·39 cites·12 claims
- 0591US6720351B2Triamide-substituted heterobicyclic compoundsPFIZER·Filed 2002·Granted Apr 13, 2004·37 cites·45 claims
- 0689US10967054B2Methods of cancer treatment using activated T cellsSYZ CELL THERAPY CO·Filed 2016·Granted Apr 6, 2021·6 cites·17 claims
- 0782US11248208B2Multiple antigen specific cell therapy methodsSYZ CELL THERAPY CO·Filed 2019·Granted Feb 15, 2022·2 cites·19 claims
- 0881US6649636B1Heteroaryl phenyl pyrazole compounds as anti-inflammatory/analgesic agentsPFIZER·Filed 2000·Granted Nov 18, 2003·18 cites·19 claims
- 0979US10266489B2Pyrrolic amide compound and preparation method and application thereofHITGEN LTD·Filed 2017·Granted Apr 23, 2019·5 cites·5 claims
- 1079US8242286B2Phenoxy-pyrrolidine derivative and its use and compositionsLI JIN·Filed 2008·Granted Aug 14, 2012·4 cites·21 claims
- 1175US12312597B2Methods of cancer treatment using activated t cellsSYZ CELL THERAPY CO·Filed 2022·Granted May 27, 2025·0 cites·19 claims
- 1274US7482368B2Triamide-substituted heterobicyclic compoundsPFIZER·Filed 2005·Granted Jan 27, 2009·1 cites·2 claims
- 1373US9999621B2Medical use of artemisinin compounds and gephyrin agonistsCEMM FORSCHUNGSZENTRUM FUER MOLEKULARE MEDIZIN GMBH·Filed 2015·Granted Jun 19, 2018·2 cites·21 claims
- 1473US8524761B2Phenoxy-pyrrolidine derivative and its use and compositionsLI JIN·Filed 2012·Granted Sep 3, 2013·2 cites·6 claims
- 1573US6531492B1Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agentsPFIZER·Filed 2000·Granted Mar 11, 2003·7 cites·12 claims
- 1672US8829001B2Dopamine D3 receptor ligands and preparation and medical uses of the sameLI JIN·Filed 2009·Granted Sep 9, 2014·2 cites·9 claims
- 1771US8252835B2Compounds and methods for treating estrogen receptor-related diseasesLI JIN·Filed 2007·Granted Aug 28, 2012·1 cites·14 claims
- 1871US6887698B2Glucuronyl C5-epimerase, DNA encoding the same and uses thereofINALCO SPA·Filed 2001·Granted May 3, 2005·3 cites·15 claims
- 1970US10987416B2Purification of recombinant EV71 virus-like particle and method for preparing vaccine thereofBEIJING MINHAI BIOTECHNOLOGY CO LTD·Filed 2016·Granted Apr 27, 2021·2 cites·8 claims
- 2070US9358532B2Catalyst for asymmetric hydrogenation of imine, synthesis method and application thereofLI JIN·Filed 2011·Granted Jun 7, 2016·1 cites·16 claims
- 2168US2024401049A1Engineered circular rna circmir-29b and use thereof in preparation of medicine for treating muscle atrophyUNIV SHANGHAI·Filed 2024·Application pending·0 cites
- 2265US7399626B2Glucuronyl C5-epimerase, DNA encoding the same and uses thereofBIOTIE THERAPIES CORP·Filed 2005·Granted Jul 15, 2008·1 cites·24 claims
- 2363US2022403384A1Engineered circular rna circmir-29b and use thereof in preparation of medicine for treating muscle atrophyUNIV SHANGHAI·Filed 2021·Application pending·0 cites
- 2462US2022235324A1Multiple antigen specific cell therapy methodsSYZ CELL THERAPY CO·Filed 2022·Application pending·0 cites
- 2562US2024368272A1Compositions and methods for treating long qt syndromeUNIV OF BERN·Filed 2022·Application pending·0 cites
- 2661US12024511B2Substituted imidazo[1,2-a]pyridin-2-ylamine compounds, and pharmaceutical compositions and methods of use thereofSHANGHAI FUDAN ZHANGJIANG BIO PHARMACEUTICAL CO LTD·Filed 2020·Granted Jul 2, 2024·0 cites·20 claims
- 2760US7348355B2Triamide-substituted heterobicyclic compoundsPFIZER·Filed 2006·Granted Mar 25, 2008·0 cites·5 claims
- 2857US10730875B2Substituted imidazo[1,2-A]pyridin-2-ylamine compounds, and pharmaceutical compositions and methods of use thereofJN THERAPEUTICS·Filed 2019·Granted Aug 4, 2020·0 cites·22 claims
- 2957US9090583B2Benzopyrone estrogen receptor regulatorDING HONGXIA·Filed 2011·Granted Jul 28, 2015·1 cites·4 claims
- 3056US9227944B2Dopamine D3 receptor ligands and preparation and medical uses of the sameINST PHARM & TOXICOLOGY AMMS·Filed 2014·Granted Jan 5, 2016·0 cites·4 claims
- 3156US8980936B2Phenoxy-pyrrolidine derivative and its use and compositionsTHESAN PHARMACEUTICALS INC·Filed 2013·Granted Mar 17, 2015·0 cites·15 claims
- 3256US2024279286A1Core amino acid sequence group capable of target recognizing anti-novel coronavirus neutralizing antibodies n-igy-pabs and use thereofSINO SWED TONGKANG BIO TECH SHENZHEN LTD·Filed 2024·Application pending·0 cites
- 3355US2024269305A1Sting agonist suitable as payload of antibody drug conjugateHITGEN INC·Filed 2024·Application pending·0 cites
- 3454US2025333409A1Compound and use thereof in preparation of BCL-XL inhibitorHITGEN INC·Filed 2023·Application pending·0 cites
- 3553US2025136593A1Degradation agent and use thereofHITGEN INC·Filed 2022·Application pending·0 cites
- 3652US8809620B2Heparanase deficient non-human mammalsLI JIN-PING·Filed 2009·Granted Aug 19, 2014·0 cites·12 claims
- 3752US2023159465A1ImmunomodulatorHITGEN INC·Filed 2022·Application pending·0 cites
- 3852US2022127602A1Grna targeting mir-29b, aav8-crisper/cas9 system and use thereofUNIV SHANGHAI·Filed 2020·Application pending·0 cites
- 3952US2025244331A1Chicken-derived recombinant full-length monoclonal igy antibody against human thymidine kinase 1 and applications thereofSINO SWED TONGKANG BIO TECH SHENZHEN LTD·Filed 2025·Application pending·0 cites
- 4051US2023227437A1ImmunomodulatorHITGEN INC·Filed 2022·Application pending·0 cites
- 4151US2010016352A1Compounds and methods for treating estrogen receptor-related diseasesLI JIN·Filed 2009·Application pending·0 cites
- 4251US2025388560A1Aromatic compound and use thereofHITGEN INC·Filed 2025·Application pending·0 cites
- 4351US2010261253A1Glucuronyl C5-Epimerase, DNA encoding the same and uses thereofBIOTIE THERAPIES CORP·Filed 2008·Application pending·0 cites
- 4450US2025368998A1Nucleotide analogues, and preparation and application thereofHITGEN INC·Filed 2025·Application pending·0 cites
- 4550US2023295610A1Dna-encoded compound library and screening method thereofHITGEN INC·Filed 2023·Application pending·0 cites
- 4650US2025074910A1Menin inhibitor and use thereofHITGEN INC·Filed 2022·Application pending·0 cites
- 4750US2023348609A1Cd40 agonistic antibody and method of useWUXI BIOLOGICS SHANGHAI CO LTD·Filed 2021·Application pending·0 cites
- 4848US2003236258A1Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agentsPFIZER·Filed 2003·Application pending·0 cites
- 4946US12486251B2CBP/EP300 inhibitor and use thereofPHARMABLOCK SCIENCES NANJING INC·Filed 2021·Granted Dec 2, 2025·0 cites·14 claims
- 5046US11078161B2Rock-inhibiting compound and uses thereofHITGEN INC·Filed 2019·Granted Aug 3, 2021·0 cites·9 claims
Showing the top 50 of 80 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Jin Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →